Tucson, AZ, United States of America

Jason Yuan

This inventor holds 1 USPTO granted patent. Top assignee: The University of Arizona. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Jason Yuan in Pharmaceutical Delivery Systems

Introduction: Jason Yuan is an esteemed inventor based in Tucson, Arizona, recognized for his significant contributions in the field of pharmaceutical sciences. With a keen focus on developing effective delivery methods for critical medical treatments, his work aims to enhance patient outcomes, particularly in the area of pulmonary arterial hypertension.

Latest Patents: Jason Yuan holds a patent for "Compositions and methods for delivering pharmaceutical agents," which provides innovative solutions for treating pulmonary arterial hypertension. His patent specifically addresses dry powder formulations of TMP designed for effective delivery to the lungs, representing a significant advancement in the administration of necessary medications.

Career Highlights: Currently, Jason Yuan is affiliated with the Arizona Board of Regents on Behalf of the University of Arizona. His work in this role underscores his commitment to research and innovation in pharmaceutical technology, where he continually seeks to bridge the gap between scientific inquiry and practical application.

Collaborations: Throughout his career, Jason Yuan has had the opportunity to collaborate with notable colleagues such as Heidi M. Mansour and Jian Wang. These partnerships highlight the collaborative spirit within research institutions, which often drives the development of pioneering solutions in healthcare.

Conclusion: Jason Yuan's inventive spirit and dedication to improving pharmaceutical delivery systems make him a noteworthy figure in contemporary medical research. His patent not only showcases his ingenuity but also holds the promise of providing better treatment options for patients suffering from pulmonary arterial hypertension. As his career progresses, the impact of his contributions is expected to resonate within the medical community and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…